Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for CG

Update shared on 01 Nov 2025

Fair value Increased 11%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
84.8%
7D
-5.2%

Centerra Gold's analyst price target increased from $16.59 to $18.41. This change reflects improved revenue growth and profit margin expectations according to recent analyst updates.

Analyst Commentary

Recent analyst actions on Centerra Gold highlight a range of opinions regarding the company's prospects. Several target price increases reflect greater optimism around Centerra Gold's execution and growth opportunities. However, some analysts have also expressed caution due to certain operational and market risks.

Bullish Takeaways
  • Bullish analysts have increased their price targets, indicating improved sentiment surrounding the company's revenue trajectory and profit margins.
  • Updates to earnings models following recent reporting periods suggest that Centerra Gold is delivering results that support higher valuations.
  • The company’s strategic assets, particularly Mount Milligan, continue to be seen as key drivers that anchor Centerra’s long-term growth and financial stability.
  • Despite ongoing capital investments, Centerra is acknowledged for its deep value. Some analysts note its potential for upside as projects advance.
Bearish Takeaways
  • Bearish analysts caution that the company’s significant investment phase introduces execution risk, especially as several major projects move forward at the same time.
  • Challenges at Mount Milligan in meeting production guidance and declining output at other sites have prompted target price reductions from some observers.
  • Concerns remain over the timing and certainty of free cash flow growth, leading some to favor producers with nearer-term upside.

What's in the News

  • The board will consider a new share repurchase program, potentially returning capital to shareholders (October 28, 2025).
  • Centerra Gold completed the repurchase of 9,195,416 shares, representing 4.43% of shares outstanding, for $64.1 million under the buyback announced in October 2024 (October 28, 2025).
  • Third quarter 2025 operating results indicate a decline in consolidated gold and copper production compared to last year (Q3 2025 results).
  • A technical study completed for the Goldfield project in Nevada confirms strong project economics, with construction scheduled to begin immediately (2025).
  • A pre-feasibility study for the Mount Milligan mine extends the projected life of the mine by about 10 years to 2045 and allows for a planned throughput increase in 2029 (2025).

Valuation Changes

  • Consensus Analyst Price Target has risen from CA$16.59 to CA$18.41, reflecting higher perceived fair value.
  • Discount Rate has declined modestly from 6.82% to 6.65%, indicating reduced risk perceptions.
  • Revenue Growth expectations have more than doubled, rising from 4.45% to 9.73%.
  • Net Profit Margin projections have increased significantly from 5.42% to 15.69%.
  • Future P/E ratio has dropped sharply from 34.60x to 10.46x, which suggests improved earnings expectations or a more attractive valuation.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.